Elevance Health Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Elevance Health stock have an average target of 584.57, with a low estimate of 552 and a high estimate of 621. The average target predicts an increase of 9.53% from the current stock price of 533.73.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$552	$584.57	$585	$621
Change	+3.42%	+9.53%	+9.61%	+16.35%

Analyst Ratings

The average analyst rating for ELV stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	4	4	4	4	4	6
Buy	8	8	8	7	8	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	12	13	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ann Hynes Mizuho	Mizuho	Strong Buy Maintains $575 → $585	Strong Buy	Maintains	$575 → $585	+9.61%	Apr 24, 2024
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $574 → $575	Buy	Maintains	$574 → $575	+7.73%	Apr 19, 2024
A.J. Rice UBS	UBS	Strong Buy Maintains $585 → $605	Strong Buy	Maintains	$585 → $605	+13.35%	Apr 19, 2024
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $557 → $600	Buy	Maintains	$557 → $600	+12.42%	Apr 19, 2024
David Macdonald Truist Securities	Truist Securities	Strong Buy Reiterates $580 → $600	Strong Buy	Reiterates	$580 → $600	+12.42%	Apr 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

174.08B

from 171.34B

1.60%

from 171.34B

Revenue Next Year

184.22B

from 174.08B

5.82%

from 174.08B

EPS This Year

37.50

from 25.22

48.70%

from 25.22

EPS Next Year

41.95

from 37.50

11.87%

from 37.50

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	104.21B	121.87B	138.64B	156.60B	171.34B	174.08B	184.22B	196.31B	233.50B	-
Revenue Growth	13.15%	16.94%	13.76%	12.95%	9.42%	1.60%	5.82%	6.57%	18.94%	-
EPS	18.47	17.98	24.95	24.28	25.22	37.50	41.95	47.32	56.14	59.05
EPS Growth	30.16%	-2.65%	38.77%	-2.69%	3.87%	48.70%	11.87%	12.78%	18.63%	5.20%
No. Analysts	-	-	-	-	-	24	22	11	4	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027
High	182.8B	196.6B	207.9B	255.6B
Avg	174.1B	184.2B	196.3B	233.5B
Low	167.7B	175.9B	186.5B	214.6B

Revenue Growth

Revenue Growth	2024	2025	2026	2027
High	6.7%	12.9%	12.9%	30.2%
Avg	1.6%	5.8%	6.6%	18.9%
Low	-2.1%	1.1%	1.2%	9.3%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	39.17	44.31	49.88	63.41	61.39
Avg	37.50	41.95	47.32	56.14	59.05
Low	36.03	40.03	44.66	51.78	57.30

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	55.3%	18.2%	18.9%	34.0%	9.4%
Avg	48.7%	11.9%	12.8%	18.6%	5.2%
Low	42.9%	6.7%	6.4%	9.4%	2.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.